Michael Webb

发表

Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2015, ACS medicinal chemistry letters.

The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2016, Bioorganic & medicinal chemistry letters.

Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2012, ACS medicinal chemistry letters.

Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

Sandy J. Wilson, Jiejun Wu, M. Karbarz, 2009, Anesthesia and analgesia.

Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.

Sandy J. Wilson, Jiejun Wu, K. Pattabiraman, 2008, Bioorganic & medicinal chemistry letters.

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Sandy J. Wilson, S. Sutton, S. Chaplan, 2006, British journal of pharmacology.

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Sandy J. Wilson, S. Sutton, S. Chaplan, 2006 .

Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).

Matthew T. Epperson, S. Chaplan, M. Seierstad, 2008, Bioorganic & medicinal chemistry letters.

Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis

J. Ma, C. Tham, Michael Webb, 2008, Neuroscience Letters.

1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2014, Bioorganic & medicinal chemistry letters.

Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.

M. Karbarz, S. Chaplan, J. Keith, 2014, Bioorganic & medicinal chemistry letters.

Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators

J. Whitaker, C. Tham, Michael Webb, 2007, FEBS letters.

Heteroarylureas with Fused Bicyclic Diamine Cores as Inhibitors of Fatty Acid Amide Hydrolase.

M. Karbarz, S. Chaplan, J. Keith, 2020, Bioorganic & medicinal chemistry letters.

Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites.

M. Karbarz, S. Chaplan, N. Hawryluk, 2012, Bioorganic & medicinal chemistry letters.

Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.

M. Karbarz, S. Chaplan, J. Keith, 2012, ACS medicinal chemistry letters.

Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).

Matthew T. Epperson, S. Chaplan, M. Seierstad, 2008, Bioorganic & medicinal chemistry letters.